Sandbox leucocytosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 468: | Line 468: | ||
| rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epithelial | * Epithelial | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Geographic tongue/Benign migratory glossitis | * Geographic tongue/Benign migratory glossitis | ||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Unknown etiology | * Unknown etiology | ||
Line 490: | Line 489: | ||
* Asthma | * Asthma | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hairy tongue | * Hairy tongue | ||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Leukoedema | * Leukoedema | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 504: | Line 501: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* White sponge nevus | * White sponge nevus | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 512: | Line 508: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hairy leukoplakia | * Hairy leukoplakia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 520: | Line 515: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lichen planus | * Lichen planus | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 528: | Line 522: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Nicotinic stomatitis | * Nicotinic stomatitis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 536: | Line 529: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hyperkeratosis | * Hyperkeratosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 544: | Line 536: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epithelial dysplasia | * Epithelial dysplasia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 552: | Line 543: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Carcinoma in-situ | * Carcinoma in-situ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 560: | Line 550: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Squamous cell carcinoma | * Squamous cell carcinoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 570: | Line 559: | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Surface debris | * Surface debris | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Candidiosis | * Candidiosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 578: | Line 566: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Burn | * Burn | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 588: | Line 575: | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Subepithelial | * Subepithelial | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Congenital keratotic cyst | * Congenital keratotic cyst | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 596: | Line 582: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Scar | * Scar | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 604: | Line 589: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Fordyce granules | * Fordyce granules | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 702: | Line 686: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Tattoo | * Tattoo | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 712: | Line 695: | ||
| rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Diffuse | * Diffuse | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hereditary | * Hereditary | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 720: | Line 702: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Addison's disease | * Addison's disease | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 728: | Line 709: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Heavy metal ingestion | * Heavy metal ingestion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 736: | Line 716: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Peutz-Jeghers syndrome | * Peutz-Jeghers syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 744: | Line 723: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Neurofibromatosis | * Neurofibromatosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 752: | Line 730: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Polyostotic fibrous dysplasia | * Polyostotic fibrous dysplasia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 760: | Line 737: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pregnancy | * Pregnancy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 768: | Line 744: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Medication | * Medication | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 776: | Line 751: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Smoker's melanosis | * Smoker's melanosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 788: | Line 762: | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hereditary | * Hereditary | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epidermolysis bullosa | * Epidermolysis bullosa | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 798: | Line 771: | ||
| rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Viral | * Viral | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Herpes simplex | * Herpes simplex | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 806: | Line 778: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Herpangina | * Herpangina | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 814: | Line 785: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hand foot and mouth disease | * Hand foot and mouth disease | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 822: | Line 792: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Herpes zoster | * Herpes zoster | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 830: | Line 799: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Infectious mononucleosis | * Infectious mononucleosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 838: | Line 806: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Varicella | * Varicella | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 848: | Line 815: | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Autoimmune | * Autoimmune | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Erosive lichen planus | * Erosive lichen planus | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 856: | Line 822: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mucous memrane pemphigoid | * Mucous memrane pemphigoid | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 864: | Line 829: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pemphigous vulgaris | * Pemphigous vulgaris | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 872: | Line 836: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Bullous pemphigoid | * Bullous pemphigoid | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 880: | Line 843: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lupus erythmatosus | * Lupus erythmatosus | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 890: | Line 852: | ||
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Idiopathic | * Idiopathic | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Aphthous ulcer | * Aphthous ulcer | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 898: | Line 859: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Erythema multiforme | * Erythema multiforme | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 906: | Line 866: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Erythroplakia | * Erythroplakia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 914: | Line 873: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Medication induced mucositis | * Medication induced mucositis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 922: | Line 880: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Contact stomatitis | * Contact stomatitis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 932: | Line 889: | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mycotic | * Mycotic | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Candidiosis | * Candidiosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,151: | Line 1,107: | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Cyst | * Cyst | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Gingival cyst of adult | * Gingival cyst of adult | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,159: | Line 1,114: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lymphoepithelial cyst | * Lymphoepithelial cyst | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,167: | Line 1,121: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epidermoid/dermoid cyst | * Epidermoid/dermoid cyst | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,175: | Line 1,128: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Thyroglossal tract cyst | * Thyroglossal tract cyst | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,185: | Line 1,137: | ||
| rowspan="10" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="10" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Malignant | * Malignant | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Squamous cell carcinoma | * Squamous cell carcinoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,193: | Line 1,144: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Verrucous carcinoma | * Verrucous carcinoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,201: | Line 1,151: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lymphoma | * Lymphoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,209: | Line 1,158: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Melanoma | * Melanoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,217: | Line 1,165: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Sarcoma | * Sarcoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,259: | Line 1,206: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Metastatic carcinoma | * Metastatic carcinoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,269: | Line 1,215: | ||
| rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Reactive | * Reactive | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Sinus track | * Sinus track | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Periodontal abscess | * Periodontal abscess | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mucocele | * Mucocele | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Fibrous hyperplasia | * Fibrous hyperplasia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Inflammatory papillary hyperplasia | * Inflammatory papillary hyperplasia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Necrotizing sialometaplasia | * Necrotizing sialometaplasia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 17:01, 24 January 2019
Disease | Presentation | Risk Factors | Diagnosis | Affected Organ Systems | Important features | Picture |
---|---|---|---|---|---|---|
Diseases predominantly affecting the oral cavity | ||||||
Oral Candidiasis |
|
|
|
Localized candidiasis
Invasive candidasis |
|
|
Herpes simplex oral lesions |
|
|
|
|
||
Aphthous ulcers |
|
|
|
|
|
|
Squamous cell carcinoma |
|
|
||||
Leukoplakia |
|
|
|
|
||
Melanoma |
|
|
|
|
||
Fordyce spots |
|
|
|
|
||
Burning mouth syndrome |
|
|
||||
Torus palatinus |
|
|||||
Diseases involving oral cavity and other organ systems | ||||||
Behcet's disease |
|
|
|
|||
Crohn's disease |
|
|
|
|||
Agranulocytosis |
|
|
||||
Syphilis |
|
|
|
|||
Coxsackie virus |
|
|
||||
Chicken pox |
|
|
|
|
||
Measles |
|
|
|
|
Surface Lesions of Oral Mucosa | Description | Location | Associated conditions | Image | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
|
|
|
|||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
Soft Tissue Lesion | Localization | Differentiating features | Diagnostic procedure | Treatment | Image | |||
|
|
|
|
|||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Type of cancer | Subtype | Epidemiology | Localization | Clinical features | Diagnostic procedures |
---|---|---|---|---|---|
Squamous cell carcinoma
|
Verrucous carcinoma |
|
|
|
Biopsy shows:
Thickened club-shaped papillae and blunt stromal invaginations of well-differentiated squamous epithelium with marked keratinization |
Lymphoepithelial carcinoma | 0.8-2% of all oral or oropharyngeal cancers |
|
|
Biopsy chows:
| |
Epithelial precursor lesions | --- | --- | Seen in the entire digestive tract |
|
Biopsy shows:
|
Proliferative verrucous leukoplakia and precancerous conditions | --- |
|
|
An aggressive form of oral leukoplakia with considerable morbidity and
strong predilection to malignant transformation |
Biopsy shows:
|
Papillomas | Squamous cell papilloma and |
|
Any oral site may be affected mostly:
|
Soft, pedunculated lesions formed by a cluster of finger-like fronds or a sessile, dome-shaped lesion with a nodular, papillary or verrucous surface | Biopsy shows:
|
Condyloma acuminatum | 2nd and 5th decade with a peak in teenagers and young adults |
|
Biopsy shows:
Several sessile, cauliflower-like swellings forming a cluster | ||
Focal epithelial hyperplasia | Disease of children, adolescents and young adults |
|
|
Biopsy shows:
| |
Granular cell tumor | --- |
|
|
|
Biopsy shows:
|
Keratoacanthoma | --- |
whites
men as in women |
|
|
Biopsy shows:
|
Papillary hyperplasia | --- | Affects all age groups | Palate | Asymptomatic nodular or papillary mucosal lesion | Biopsy shows:
|
Median rhomboid glossitis | --- | --- | Dorsum of the tongue at the junction of the anterior two thirds
and posterior third |
Forms a patch of papillary atrophy in the region of the
embryological foramen caecum |
Biopsy shows:
|
Salivary gland tumors | Acinic cell carcinoma |
|
Tumors usually
form non-descript swellings |
Biopsy shows:
| |
Mucoepidermoid carcinoma |
|
|
|
Low power microscopy shows low-grade tumor with both cystic and solid areas and an inflamed, fibrous stroma | |
Adenoid cystic carcinoma |
|
|
Predominantly solid variant shows peri- and intraneural invasion | ||
Epithelial-myoepithelial
carcinoma |
--- | --- | --- | --- | |
Clear cell carcinoma,
NOS |
--- | --- | --- | ||
Basal cell | Rare in minor glands | Asymptomatic, smooth or lobulated sub-mucosal masses | Microscopically similar to basal
cell adenocarcinomas of the major gland | ||
Cystadenocarcinoma | 32% developed in the minor glands |
|
Slow growing and painless but
some palatal tumors may erode the underlying bone causing sinonasal complex |
--- | |
Salivary duct carcinoma |
|
|
Tumors formed painless swellings but many in the palate can be painful and ulcerated or fungated with metastases to regional lymph nodes | The range of
microscopical appearances is similar to that seen in the major glands | |
Salivary gland adenomas | Pleomorphic adenoma | 40-70% of minor gland tumors |
|
Painless, slow growing, submucosal masses, but when | Biopsy shows cellular, and hyaline or plasmacytoid cell |
Myoepithelioma | 42% of minor gland tumors |
|
--- | --- | |
Basal cell adenoma | 20% of minor gland tumors | --- | They are histologically
similar to those in major glands. | ||
Cystadenoma | 7% of benign minor gland tumors | --- | --- | ||
Kaposi sarcoma | --- |
|
|
Biopsy of all 4 types show:
| |
Lymphangioma | --- |
|
Tongue |
|
Biopsy shows:
|
Ectomesenchymal chondromyxoid
tumour of the anterior tongue |
--- |
|
--- | Asymptomatic, slow growing solitary nodule in the anterior dorsal tongue | Biopsy shows:
|
Focal oral mucinosis (FOM) | --- |
|
Asymptomatic fibrous or cystic-like lesion | Histopathology is characterized by:
| |
Congenital granular cell epuli | --- |
|
Solitary, somewhat pedunculated fibroma-like lesion attached to the alveolar
ridge near the midline |
||
Hematolymphoid tumors | Non-Hodgkin lymphoma | Second most common cancer of the oral cavity |
|
NHL of the lip presents with:
|
Biopsy shows:
|
Langerhans cell histiocytosis | --- |
and |
Common oral symptoms
include:
|
Biopsy shows ovoid Langerhans cells
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm | |
Hodgkin lymphoma | --- |
|
Most patients present with localized disease (stage I/II), with
|
--- | |
Extramedullary myeloid
sarcoma |
--- | Isolated tumor-forming intraoral mass | Biopsy shows an Indian-file pattern of infiltration | ||
Follicular dendritic cell
sarcoma / tumour |
|
|
The patients usually
present with a painless mass |
Biopsy usually exhibits
borders and comprises:
| |
Mucosal malignant melanoma | --- |
|
80% arise:
Others:
|
|
|